Loading...
Loading...
$1.5M
Awarded Jun 24, 2026
Competition
FULL AND OPEN COMPETITION
Offers
18
Set-Aside
None
Solicitation Type
RFP - Negotiated
Program
ADVANCED DEVELOPMENT AND VALIDATION OF THE CELLRADX QUALITATIVE BIODOSIMETRY TRIAGE TEST
Performance Timeline
Start
Jul 1, 2026
Recompete planning should begin soon.
Contract: 75N93026C00006
UEI
ZC5MF9MRE3A5
Parent Company
ASELL, LLC
Capabilities & Certifications
Headquarters Location
Congressional District: 02
Current Obligation
$1,492,621
Base + Exercised Options
$1,492,621
Total Ceiling Value
$4,477,909
Contract Type
COST PLUS FIXED FEE
Multi-Year Contract
NO
Description
DEVELOPMENT OF RADIATION/NUCLEAR MEDICAL COUNTERMEASURES (MCMS) AND BIODOSIMETRY DEVICES. 7/1/26 - 6/30/27. EO 14271: DAP-NCAP-00000073
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Place of Performance
Congressional District: 02
Awarding Agency
Top-tier Agency
National Institutes of Health
Sub-tier Agency
NATIONAL INSTITUTES OF HEALTH NIAID
Office
Funding Agency
Top-tier Agency
National Institutes of Health
Sub-tier Agency
NATIONAL INSTITUTES OF HEALTH NIAID
Office